Contents
Issue 139 • February 2024
In association with
In Depth
Inside the world of priority review vouchers where time is money
Quality and sustainability: The balancing act for pharma manufacturing
2023 in review: Cancer vaccines dose up on advances with tailored approaches
Diversity and ePROs: Still siloed concepts in the era of DCTs?
Q&A: Tackling the rise of fake anti-obesity drugs on the market
Patching the problem of EU drug shortages
Out-of-spec cell therapy manufacturing: an ethical dilemma for CDMOs
Thematic Take
Internet of Things in pharma
Powered by
